All articles by mohamed elseman
mohamed elseman
BioLineRx gets US patent covering use of BL-8040 in immunotherapy
Israel-based clinical-stage biopharmaceutical firm BioLineRx has announced that an Issue of Notification has been received from the US Patent and Trademark Office (USPTO) for US Patent No. 8,663,651.
Bayer to acquire Chinese OTC drug-maker Dihon
Bayer is planning to acquire 100% shares of China-based provider of over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products, Dihon Pharmaceutical Group.